(NASDAQ: BIOX) Bioceres Crop Solutions's forecast annual revenue growth rate of 19.57% is not forecast to beat the US Agricultural Inputs industry's average forecast revenue growth rate of 23.05%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.23%.
Bioceres Crop Solutions's revenue in 2024 is $450,321,282.On average, 2 Wall Street analysts forecast BIOX's revenue for 2024 to be $30,358,501,680, with the lowest BIOX revenue forecast at $30,327,087,668, and the highest BIOX revenue forecast at $30,389,915,693. On average, 2 Wall Street analysts forecast BIOX's revenue for 2025 to be $38,482,165,313, with the lowest BIOX revenue forecast at $37,150,211,183, and the highest BIOX revenue forecast at $39,814,119,443.
In 2026, BIOX is forecast to generate $49,074,970,328 in revenue, with the lowest revenue forecast at $49,074,970,328 and the highest revenue forecast at $49,074,970,328.